Envista Holdings Co. (NYSE:NVST – Get Free Report) has been given an average rating of “Hold” by the fourteen brokerages that are currently covering the stock, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell recommendation, eight have assigned a hold recommendation and three have given a buy recommendation to the company. The average 1 year price target among brokerages that have covered the stock in the last year is $19.59.
Several research analysts have recently weighed in on NVST shares. Stifel Nicolaus lowered their price objective on Envista from $20.00 to $18.00 and set a “buy” rating for the company in a research report on Tuesday, July 30th. Piper Sandler dropped their price target on Envista from $18.00 to $16.00 and set a “neutral” rating on the stock in a research note on Tuesday, July 30th. Bank of America lowered their price objective on shares of Envista from $22.00 to $19.00 and set a “buy” rating for the company in a research note on Thursday, August 8th. Evercore ISI increased their target price on shares of Envista from $18.00 to $23.00 and gave the stock an “outperform” rating in a research note on Monday. Finally, Needham & Company LLC restated a “hold” rating on shares of Envista in a report on Thursday, August 8th.
View Our Latest Report on NVST
Insider Activity at Envista
Institutional Trading of Envista
Several institutional investors have recently made changes to their positions in the company. Versant Capital Management Inc boosted its holdings in Envista by 1,420.3% during the second quarter. Versant Capital Management Inc now owns 3,147 shares of the company’s stock worth $52,000 after purchasing an additional 2,940 shares during the last quarter. Quadrant Capital Group LLC boosted its stake in shares of Envista by 538.0% in the 4th quarter. Quadrant Capital Group LLC now owns 3,209 shares of the company’s stock worth $77,000 after buying an additional 2,706 shares during the last quarter. Innealta Capital LLC bought a new position in shares of Envista in the second quarter valued at approximately $78,000. Summit Securities Group LLC purchased a new stake in shares of Envista during the second quarter valued at approximately $85,000. Finally, Signaturefd LLC lifted its holdings in Envista by 85.9% during the second quarter. Signaturefd LLC now owns 5,345 shares of the company’s stock worth $89,000 after acquiring an additional 2,470 shares during the period.
Envista Price Performance
Envista stock opened at $18.64 on Friday. The firm has a market cap of $3.21 billion, a P/E ratio of -25.94 and a beta of 1.31. The stock’s 50 day moving average is $17.52 and its 200 day moving average is $18.44. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.22 and a quick ratio of 1.90. Envista has a one year low of $15.15 and a one year high of $28.67.
Envista (NYSE:NVST – Get Free Report) last posted its quarterly earnings data on Wednesday, August 7th. The company reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.27 by ($0.16). Envista had a negative net margin of 52.25% and a positive return on equity of 4.86%. The firm had revenue of $633.10 million during the quarter, compared to the consensus estimate of $646.88 million. During the same period in the prior year, the company posted $0.43 earnings per share. The company’s revenue for the quarter was down 4.4% compared to the same quarter last year. As a group, research analysts expect that Envista will post 0.69 EPS for the current year.
About Envista
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Further Reading
- Five stocks we like better than Envista
- Transportation Stocks Investing
- Should You Invest in Treasury Bills?
- 5 Top Rated Dividend Stocks to Consider
- Analysts Think There’s Still Time to Get in on Edgewise, Up 332%
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- 3 Stocks Raising Dividends 4X Higher Than Inflation
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.